NCT05903170 - Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

August 31, 2026

Conditions

Atrial Fibrillation

Interventions

DEVICE

360J LifePak Monitor/Defibrillator

The LifePak Monitor/Defibrillator is a commonly-used defibrillator in New Zealand hospitals for cardioverting atrial fibrillation. It delivers a biphasic waveform shock with a titratable maximum energy of 360J.

DEVICE

200J Philips HeartStart MRx Monitor/Defibrillator

The Philips HeartStart MRx Monitor/Defibrillator is a commonly-used defibrillator in New Zealand hospitals for cardioverting atrial fibrillation. It delivers a biphasic waveform shock with a titratable maximum energy of 200J.

Trial Locations (1)

6012

RECRUITING

Wellington Regional Hospital, Wellington

All Listed Sponsors

lead

Wellington Hospital

OTHER_GOV